CAS: 2097938-64-0
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | N-[4-(3-Aminopiperidin-1-yl)-5-bromo-1H-indol-3-yl]cyclopropanecarboxamide REF: 3D-XID93864CAS: 2097938-64-0 | Min. 95% | 553,00 €~4.833,00 € | Mar 15 Abr 25 |
 | CHK1 inhibitor REF: TM-T10793CAS: 2097938-64-0 | 98% | 1.374,00 €~3.800,00 € | Mar 03 Jun 25 |
![N-[4-(3-Aminopiperidin-1-yl)-5-bromo-1H-indol-3-yl]cyclopropanecarboxamide](https://static.cymitquimica.com/products/3D/thumb/XID93864.jpg)
N-[4-(3-Aminopiperidin-1-yl)-5-bromo-1H-indol-3-yl]cyclopropanecarboxamide
CAS:2097938-64-0
Gemcitabine is a cytotoxic drug that inhibits cell growth by binding to the ribonucleotide reductase …
Fórmula:
C17H21BrN4O
Pureza:
Min. 95%
Peso molecular:
377.3 g/mol
Ref: 3D-XID93864
| 1mg | 553,00 € | ||
| 5mg | 1.611,00 € | ||
| 10mg | 2.578,00 € | ||
| 25mg | 4.833,00 € |
Entrega estimada en Estados Unidos, el Martes 15 de Abril de 2025
CHK1 inhibitor
CAS:2097938-64-0
CHK1 inhibitor (GDC-0575 analog) is a CHK1 inhibitor.
Fórmula:
C17H21BrN4O
Pureza:
98%
Forma y color:
Solid
Peso molecular:
377.28
Ref: TM-T10793
| 25mg | 2.157,00 € | ||
| 50mg | 2.832,00 € | ||
| 100mg | 3.800,00 € |
Entrega estimada en Estados Unidos, el Martes 3 de Junio de 2025
